Minimally invasive image-guided therapies for hepatocellular carcinoma

References

• JemalABrayFCenterMMFerlayJWardEFormanDGlobal cancer statisticsCA Cancer J Clin2011612699021296855
   PubMed Web of Science ®Google Scholar
• BruixJShermanMAmerican Association for the Study of Liver DiseaseManagement of hepatocellular carcinoma: an updateHepatology20115331020102221374666
   PubMed Web of Science ®Google Scholar
• LencioniRLoco-regional treatment of hepatocellular carcinomaHepatology201052276277320564355
   PubMed Web of Science ®Google Scholar
• LivraghiTBolondiLLazzaroniSPercutaneous ethanol injection in the treatment of hepatocellular carcinoma in cirrhosis. A study on 207 patientsCancer19926949259291310435
   PubMed Web of Science ®Google Scholar
• SalaMLlovetJMVilanaRInitial response to percutaneous ablation predicts survival in patients with hepatocellular carcinomaHepatology20044061352136015565564
   PubMed Web of Science ®Google Scholar
• ShiinaSTerataniTObiSA randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinomaGastroenterology2005129112213016012942
   PubMed Web of Science ®Google Scholar
• LinSMLinCJLinCCHsuCWChenYCRandomised controlled trial comparing percutaneous radiofrequency thermal ablation, percutaneous ethanol injection, and percutaneous acetic acid injection to treat hepatocellular carcinoma of 3 cm or lessGut20055481151115616009687
   PubMed Web of Science ®Google Scholar
• AhrarKMatinSWoodCGPercutaneous radiofrequency ablation of renal tumors: technique, complications, and outcomesJ Vasc Interv Radiol200516567968815872323
   PubMed Web of Science ®Google Scholar
• HongSNLeeSYChoiMSComparing the outcomes of radiofrequency ablation and surgery in patients with a single small hepatocellular carcinoma and well-preserved hepatic functionJ Clin Gastroenterol200539324725215718869
   PubMed Web of Science ®Google Scholar
• ChoCMTakWYKweonYOThe comparative results of radiofrequency ablation versus surgical resection for the treatment of hepatocellular carcinomaKorean J Hepatol20051115971 Korean15788886
   PubMedGoogle Scholar
• ZhouDCGengXPZhuLXZhaoHCLiuFBZhaoYJPercutaneous radiofrequency ablation versus hepatic resection for small hepatocellular carcinoma: a meta analysisZhonghua wai ke za zhi2011491211321136 Chinese22333458
   PubMedGoogle Scholar
• LiuZZhouYZhangPQinHMeta-analysis of the therapeutic effect of hepatectomy versus radiofrequency ablation for the treatment of hepatocellular carcinomaSurg Laparosc Endosc Percutan Tech201020313014020551807
   PubMed Web of Science ®Google Scholar
• ChenMSLiJQZhengYA prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinomaAnn Surg2006243332132816495695
   PubMed Web of Science ®Google Scholar
• HuangJYanLChengZA randomized trial comparing radio-frequency ablation and surgical resection for HCC conforming to the Milan criteriaAnn Surg2010252690391221107100
   PubMed Web of Science ®Google Scholar
• FengKYanJLiXA randomized controlled trial of radio-frequency ablation and surgical resection in the treatment of small hepatocellular carcinomaJ Hepatol201257479480222634125
   PubMed Web of Science ®Google Scholar
• LuMDKuangMLiangLJSurgical resection versus percutaneous thermal ablation for early-stage hepatocellular carcinoma: a randomized clinical trialZhonghua yi xue za zhi20068612801805 Chinese16681964
   PubMedGoogle Scholar
• LivraghiTMeloniFDi StasiMSustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: is resection still the treatment of choice?Hepatology2008471828918008357
   PubMed Web of Science ®Google Scholar
• LubnerMGBraceCLHinshawJLLeeFTJrMicrowave tumor ablation: mechanism of action, clinical results, and devicesJ Vasc Interv Radiol2010218 SupplS192S20320656229
   PubMed Web of Science ®Google Scholar
• LiangPWangYMicrowave ablation of hepatocellular carcinomaOncology200772Suppl 112413118087193
   PubMed Web of Science ®Google Scholar
• PoggiGMontagnaBDI CesarePRivaGBernardoGMazzuccoMRiccardiAMicrowave ablation of hepatocellular carcinoma using a new percutaneous device: preliminary resultsAnticancer Res20133331221122723482806
   PubMed Web of Science ®Google Scholar
• ZhangLWangNShenQChengWQianGJTherapeutic efficacy of percutaneous radiofrequency ablation versus microwave ablation for hepatocellular carcinomaPLoS One2013810e7611924146824
   PubMed Web of Science ®Google Scholar
• LeeSMWonJYLeeDYPercutaneous cryoablation of small hepatocellular carcinomas using a 17-gauge ultrathin probeClinical Radiol2011668752759
   PubMed Web of Science ®Google Scholar
• BageacuSKaczmarekDLacroixMDuboisJForestJPorcheronJCryosurgery for resectable and unresectable hepatic metastases from colorectal cancerEur J Surg Oncol200733559059617321714
   PubMed Web of Science ®Google Scholar
• SeifertJKFranceMPZhaoJBoltonEJFinlayIJungingerTMorrisDLLarge volume hepatic freezing: association with significant release of the cytokines interleukin-6 and tumor necrosis factor a in a rat modelWorld J Surg200226111333134112297923
   PubMed Web of Science ®Google Scholar
• SheenAJPostonGJSherlockDJCryotherapeutic ablation of liver tumoursBr J Surg200289111396140112390380
   PubMed Web of Science ®Google Scholar
• LammerJMalagariKVoglTProspective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V studyCardiovasc Interv Radiol20103314152
   PubMed Web of Science ®Google Scholar
• VoglTJLammerJLencioniRLiver, gastrointestinal, and cardiac toxicity in intermediate hepatocellular carcinoma treated with PRECISION TACE with drug-eluting beads: results from the PRECISION V randomized trialAJR Am J Roentgenol20111974W562W57021940527
   PubMed Web of Science ®Google Scholar
• LlovetJMBruixJSystematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survivalHepatology200337242944212540794
   PubMed Web of Science ®Google Scholar
• BurrelMReigMFornerASurvival of patients with hepatocellular carcinoma treated by transarterial chemoembolisation (TACE) using drug eluting beads. Implications for clinical practice and trial designJ Hepatol20125661330133522314428
   PubMed Web of Science ®Google Scholar
• YaoFYKinkhabwalaMLaBergeJMThe impact of pre-operative loco-regional therapy on outcome after liver transplantation for hepatocellular carcinomaAm J Transplant200554 Pt 179580415760404
   PubMed Web of Science ®Google Scholar
• YaoFYHiroseRLaBergeJMA prospective study on downstaging of hepatocellular carcinoma prior to liver transplantationLiver Transplant2005111215051514
   PubMed Web of Science ®Google Scholar
• MeyerTKirkwoodARoughtonMA randomised phase II/III trial of 3-weekly cisplatin-based sequential transarterial chemoembolisation vs embolisation alone for hepatocellular carcinomaBr J Cancer201310861252125923449352
   PubMed Web of Science ®Google Scholar
• KlugerMDHalazunKJBarrosoRTBland embolization versus chemoembolization of hepatocellular carcinoma before transplantationLiver Transplant2014205536543
   Web of Science ®Google Scholar
• BrownKTDoRKGonenMRandomized trial of hepatic artery embolization for hepatocellular carcinoma using doxorubicin-eluting microspheres compared with embolization with microspheres aloneJ Clin Oncol201634172046205326834067
   PubMed Web of Science ®Google Scholar
• IngoldJAReedGBKaplanHSBagshawMARadiation hepatitisAm J Roentgenol Radium Ther Nucl Med196593200208
   PubMedGoogle Scholar
• LawrenceTSRobertsonJMAnscherMSJirtleRLEnsmingerWDFajardoLFHepatic toxicity resulting from cancer treatmentInt J Radiat Oncol Biol Phys1995315123712487713785
   PubMed Web of Science ®Google Scholar
• MazzaferroVSpositoCBhooriSYttrium-90 radioembolization for intermediate-advanced hepatocellular carcinoma: a phase 2 studyHepatology20135751826183722911442
   PubMed Web of Science ®Google Scholar
• SalemRLewandowskiRJMulcahyMFRadioembolization for hepatocellular carcinoma using Yttrium-90 microspheres: a comprehensive report of long-term outcomesGastroenterology20101381526419766639
   PubMed Web of Science ®Google Scholar
• VeltriAMorettoPDoriguzziAPaganoECarraraGGandiniGRadiofrequency thermal ablation (RFA) after transarterial chemoembolization (TACE) as a combined therapy for unresectable non-early hepatocellular carcinoma (HCC)Eur Radiol200616366166916228211
   PubMed Web of Science ®Google Scholar
• RossiSGarbagnatiFLencioniRPercutaneous radio-frequency thermal ablation of nonresectable hepatocellular carcinoma after occlusion of tumor blood supplyRadiology2000217111912611012432
   PubMed Web of Science ®Google Scholar
• MorimotoMNumataKKondoMMoriyaSMoritaSMaedaSTanakaKRadiofrequency ablation combined with transarterial chemoembolization for subcapsular hepatocellular carcinoma: a prospective cohort studyEur J Radiol201382349750323068563
   PubMed Web of Science ®Google Scholar
• MorimotoMNumataKKondouMNozakiAMoritaSTanakaKMidterm outcomes in patients with intermediate-sized hepatocellular carcinoma: a randomized controlled trial for determining the efficacy of radiofrequency ablation combined with transcatheter arterial chemoembolizationCancer2010116235452546020672352
   PubMed Web of Science ®Google Scholar
• LencioniRCrocettiLPetruzziPDoxorubicin-eluting bead-enhanced radiofrequency ablation of hepatocellular carcinoma: a pilot clinical studyJ Hepatol200849221722218486261
   PubMed Web of Science ®Google Scholar
• YamasakiTKurokawaFShirahashiHKusanoNHironakaKOkitaKPercutaneous radiofrequency ablation therapy for patients with hepatocellular carcinoma during occlusion of hepatic blood flow. Comparison with standard percutaneous radiofrequency ablation therapyCancer200295112353236012436442
   PubMed Web of Science ®Google Scholar
• LlovetJMRicciSMazzaferroVSorafenib in advanced hepatocellular carcinomaN Engl J Med2008359437839018650514
   PubMed Web of Science ®Google Scholar
• ChengALKangYKChenZEfficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trialLancet Oncol2009101253419095497
   PubMed Web of Science ®Google Scholar
• ChowPKPoonDYKhinMWMulticenter phase II study of sequential radioembolization-sorafenib therapy for inoperable hepatocellular carcinomaPLoS One201493e9090924614178
   PubMed Web of Science ®Google Scholar
• PawlikTMReyesDKCosgroveDKamelIRBhagatNGeschwindJFPhase II trial of sorafenib combined with concurrent transarterial chemoembolization with drug-eluting beads for hepatocellular carcinomaJ Clin Oncol201129303960396721911714
   PubMed Web of Science ®Google Scholar
• ParkJWKohYHKimHBPhase II study of concurrent transarterial chemoembolization and sorafenib in patients with unresectable hepatocellular carcinomaJ Hepatol20125661336134222314421
   PubMed Web of Science ®Google Scholar
• ChoiGHShimJHKimMJSorafenib alone versus sorafenib combined with transarterial chemoembolization for advanced-stage hepatocellular carcinoma: results of propensity score analysesRadiology2013269260361123864102
   PubMed Web of Science ®Google Scholar
• QuXDChenCSWangJHThe efficacy of TACE combined sorafenib in advanced stages hepatocellullar carcinomaBMC Cancer20121226322721173
   PubMed Web of Science ®Google Scholar
• MahvashAMurthyROdisioBCYttrium-90 resin microspheres as an adjunct to sorafenib in patients with unresectable hepatocellular carcinomaJ Hepatocell Carcinoma201631727574586
   PubMedGoogle Scholar
• MillerLLeorJRubinskyBCancer cells ablation with irreversible electroporationTechnol Cancer Res Treat20054669970516292891
   PubMed Web of Science ®Google Scholar
• RubinskyBIrreversible electroporation in medicineTechnol Cancer Res Treat20076425526017668932
   PubMed Web of Science ®Google Scholar
• RubinskyBOnikGMikusPIrreversible electroporation: a new ablation modality – clinical implicationsTechnol Cancer Res Treat200761374817241099
   PubMed Web of Science ®Google Scholar
• EddJFHorowitzLDavalosRVMirLMRubinskyBIn vivo results of a new focal tissue ablation technique: irreversible electroporationIEEE Trans Biomed Eng20065371409141516830945
   PubMed Web of Science ®Google Scholar
• Ben-DavidEAppelbaumLSosnaJNissenbaumIGoldbergSNCharacterization of irreversible electroporation ablation in in vivo porcine liverAJR Am J Roentgenol20121981W62W6822194517
   PubMed Web of Science ®Google Scholar
• DeodharAMonetteSSingleGWJrPercutaneous irreversible electroporation lung ablation: preliminary results in a porcine modelCardiovasc Intervent Radiol20113461278128721455641
   PubMed Web of Science ®Google Scholar
• CharpentierKPWolfFNobleLWinnBResnickMDupuyDEIrreversible electroporation of the liver and liver hilum in swineHPB (Oxford)201113316817321309933
   PubMed Web of Science ®Google Scholar
• OnikGMikusPRubinskyBIrreversible electroporation: implications for prostate ablationTechnol Cancer Res Treat20076429530017668936
   PubMed Web of Science ®Google Scholar
• PechMJanitzkyAWendlerJJIrreversible electroporation of renal cell carcinoma: a first-in-man phase I clinical studyCardiovasc Intervent Radiol201134113213820711837
   PubMed Web of Science ®Google Scholar
• LencioniRCioniDDella PinaCCrocettiLHepatocellular carcinoma: new options for image-guided ablationJ Hepatobiliary Pancreat Sci201017439940320091187
   PubMed Web of Science ®Google Scholar